BNTX - BioNTech SE
97.465
-2.845 -2.919%
Share volume: 676,999
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$100.31
-2.84
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 05-08-2023 | 08-07-2023 | 11-06-2023 | 03-20-2024 | 05-06-2024 | |
| Assets | ||||||
| Total Assets | 24.073 B | 24.161 B | 23.496 B | 25.435 B | 24.038 B | |
| Current Assets | 21.901 B | 20.887 B | 19.837 B | 21.588 B | 19.736 B | |
| Inventories | 462.410 M | 487.991 M | 439.824 M | 395.455 M | 373.036 M | |
| Other Current Assets | 1.164 B | 2.109 B | 3.000 B | 5.915 B | 7.897 B | |
| Short Term Investments | 1.164 B | 2.109 B | 3.000 B | 5.915 B | 7.897 B | |
| Total Receivables | 7.033 B | 2.889 B | 2.118 B | 2.383 B | 1.771 B | |
| Current Cash | 13.241 B | 15.400 B | 14.279 B | 12.895 B | 9.695 B | |
| Total Non-current Assets | 2.173 B | 3.274 B | 3.659 B | 3.846 B | 4.301 B | |
| Property Plant Equipment | 696.941 M | 751.282 M | 771.200 M | 837.123 M | 866.816 M | |
| Other Assets | 795.507 M | 1.717 B | 1.576 B | 1.629 B | 2.051 B | |
| Intangible Assets | 412.800 M | 545.063 M | 704.121 M | 888.973 M | 887.445 M | |
| Goodwill | 0.000 | 0.000 | 386.817 M | 400.762 M | 398.200 M | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 24.073 B | 24.161 B | 23.496 B | 25.435 B | 24.038 B | |
| Total liabilities | 1.978 B | 2.521 B | 2.476 B | 3.052 B | 2.472 B | |
| Total current liabilities | 1.691 B | 1.977 B | 1.912 B | 2.289 B | 1.734 B | |
| Accounts Payable | 32.601 M | 248.507 M | 235.624 M | 391.365 M | 322.707 M | |
| Other liabilities | 92.787 M | 357.106 M | 347.246 M | 507.669 M | 473.261 M | |
| Current long term debt | 40.778 M | 41.961 M | 42.321 M | 31.066 M | 33.804 M | |
| Long term debt | 187.973 M | 181.651 M | 171.296 M | 211.160 M | 221.402 M | |
| Other liabilities | 92.787 M | 357.106 M | 347.246 M | 507.669 M | 473.261 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 22.096 B | 21.640 B | 21.020 B | 22.383 B | 21.566 B | |
| Common stock | 242.609 M | 241.013 M | 239.701 M | 239.077 M | 240.534 M | |
| Retained earnings | 21.082 B | 20.812 B | 20.426 B | 21.849 B | 21.004 B |